60 DEGREES PHARMACEUTICALS, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | $-7.4M | $-7.9M | $-3.8M | $-6.2M |
| Depreciation & Amortization | $43.3K | $11.7K | $21.2K | — |
| Depreciation | $43.3K | $11.7K | $21.2K | $27.6K |
| Amortization | $39.5K | $38.5K | $29.2K | $5.1K |
| Stock-Based Compensation | — | — | $212.6K | — |
| Net Cash from Operating Activities | $-6.8M | $-5.6M | $-4.5M | $-1.0M |
| Investing Activities | ||||
| Capital Expenditures | $139.9K | $103.8K | $57.6K | — |
| Business Acquisitions | — | — | — | — |
| Net Cash from Investing Activities | $254.9K | $-1.9M | $-115.9K | $-60.1K |
| Financing Activities | ||||
| Dividends Paid | — | — | — | — |
| Stock Repurchases | — | — | — | — |
| Net Cash from Financing Activities | $6.4M | $7.1M | $6.5M | $1.2M |
| Net Change in Cash | $-149.3K | $-483.1K | $1.9M | $149.5K |
| Free Cash Flow | $-7.0M | $-5.8M | $-4.6M | — |